ArticleImmunity, inflammation and disease2021
Serum triglyceride levels and related factors as prognostic indicators in COVID-19 patients: A retrospective study.
Article in Immunity, inflammation and disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.
- Association of Lipid Levels With COVID-19 Infection, Disease Severity and Mortality: A Systematic Review and Meta-Analysis.Frontiers in cardiovascular medicine · 2022Pooled it
- Recent advances in nutritional metabolism studies on SARS-CoV-2 infection.Infectious medicine · 2025Review
- Investigating the relationship between cycle threshold of SARS-CoV-2 RT-PCR, clinical features, and laboratory data in hospitalized COVID-19 patients in Semnan, Iran.Frontiers in cellular and infection microbiology · 2025Article
- Type 2 diabetes and susceptibility to COVID-19: a machine learning analysis.BMC endocrine disorders · 2024Article
- Interplay between LPL and GPIHBP1 in COVID-19 patients: a possible mechanism for post-recovery cardiomyopathy.Human cell · 2023Article
- Biomarkers of glucose homeostasis as mediators of the relationship of body mass index and waist circumference with COVID-19 outcomes among postmenopausal women: The Women's Health Initiative.Clinical nutrition (Edinburgh, Scotland) · 2023Article
- Shared genetic influences between blood analyte levels and risk of severe COVID-19.Cell reports · 2022Article
- Triglyceride/High-Density Lipoprotein Cholesterol Ratio is Associated with the Mortality of COVID-19: A Retrospective Study in China.International journal of general medicine · 2022Article
- Serum triglyceride levels and related factors as prognostic indicators in COVID-19 patients: A retrospective study.Immunity, inflammation and disease · 2021Article
- Innate and Adaptive Immune Assessment at Admission to Predict Clinical Outcome in COVID-19 Patients.Biomedicines · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
The role of triglycerides (TG) in coronavirus disease (COVID-19) is controversial. The objective of this study was to explore the relationship between TG levels and prognosis in COVID-19 patients and investigate the factors that affect TG. COVID-19 patients were divided into normal or high TG level groups. Their demographic data, medical history, signs and symptoms, laboratory results, and final clinical results were analyzed retrospectively. A total of 174 patients were included. TG level was 1.6 (interquartile range [IQR]: 1.1-2.1) mmol/L for all patients; 2.2 (IQR: 1.8-2.7) mmol/L and 1.1 (IQR: 1.0-1.3) mmol/L in the high TG and control groups, respectively. Overall, 29 patients (16.7%) died during hospitalization, including 19 (23.1%) in the high TG group and 10 (11.5%) in the control group (absolute survival difference, 2.5% (95% confidence interval [CI], 1.2%-5.1%), log-rank χ
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.